Phase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis
Clinical trial NCT00530075 · COMPLETED
Trial details
- NCT number
- NCT00530075
- Sponsor
- Nippon Kayaku Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-01
- Primary completion
- 2006-02-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.